The principle: organized around clinical questions
Conventional medicine often organizes testing around what's quick, inexpensive, and standardized. That approach works well for acute illness and for the conditions standard testing was designed to identify. It works less well for the chronic, multi-system, often-undiagnosed illness that brings most patients to iHeal.
Our evaluation organizes around clinical questions instead. The questions are shaped by the patient's history, symptoms, exposures, and the patterns that emerge during the initial consultation. Each clinical question points toward specific categories of testing. The result is an evaluation that's both more comprehensive than standard workups and more targeted — we test what the clinical picture indicates, not everything available and not only the standard minimum.
Conventional baseline: the foundation
Comprehensive evaluation begins with thorough conventional testing. This is not a step we skip or minimize. Standard laboratories — LabCorp, Quest Diagnostics, and hospital-based labs — perform the foundational work: complete blood count, comprehensive metabolic panel, standard lipid panel, inflammatory markers, standard thyroid testing, nutrient markers, urinalysis, and the broad range of conventional diagnostics. We rely on these laboratories for what they do well, which is a great deal.
Much of the time, the conventional baseline identifies findings that have been missed simply because no one ordered the test or connected the results. A thorough conventional evaluation, carefully interpreted, is itself more than many patients have received. The specialty testing that follows extends the conventional baseline; it does not replace it.
Specialty inflammation and immune function
When the clinical question involves immune dysregulation, mast cell activation, or chronic inflammatory illness, the evaluation extends to specialty testing. This may include mast cell mediator testing, expanded inflammatory profiling beyond standard CRP, lymphocyte subset analysis, and markers relevant to specific inflammatory conditions. The selection depends on whether the clinical question is about mast cell activation, autoimmune patterns, chronic inflammatory response, or another specific immune issue.
Environmental exposure assessment
When the clinical question involves environmental drivers — mold and mycotoxins, heavy metals, or chemical exposures — the evaluation uses specialty laboratories that test for these specific exposures. Mycotoxin testing identifies exposure to the specific toxins associated with food-borne or water-damaged building mold. Heavy metal evaluation uses the testing approaches appropriate to the metal and exposure pattern in question, including provoked urinary testing when the clinical question is whether tissue-stored metal burden is contributing to the patient's illness. Testing for environmental chemicals — pesticides, plasticizers, PFAS — is available when the exposure history and clinical picture indicate it.
Several specialty laboratories serve these clinical questions; the choice among them depends on what's being evaluated and which laboratory's methodology best answers the specific question. The evaluation is not locked to any single laboratory — it's matched to the clinical question.
Specialty infection testing
When the clinical question involves chronic infection — tick-borne disease, chronic viral reactivation, parasitic infection, or gut microbial issues — the evaluation extends beyond standard infectious disease testing. Tick-borne disease evaluation uses both standard serology and the specialty testing that improves diagnostic yield. Chronic viral assessment characterizes EBV and CMV activity patterns rather than relying on single antibody titers. Parasitic evaluation relies substantially on expert microscopic examination — which, performed with proper preparation, staining, and the expertise of an experienced parasitologist, remains the most consistent method for identifying the range of parasitic organisms. Gut microbial assessment uses specialty stool analysis and breath testing as the clinical question indicates.
The interpretation of specialty infection testing requires clinical correlation. These tests have known limitations; a negative result in a patient with a strongly consistent clinical picture does not rule out infection, and a positive result is interpreted in the context of the whole clinical presentation.
Functional and metabolic testing
When the clinical question involves metabolic health, cardiovascular risk, mitochondrial function, or hormonal patterns, the evaluation uses advanced testing that extends well beyond standard panels. Advanced metabolic and lipid testing — Cardio IQ-style panels — reveals lipoprotein particle patterns, insulin resistance, and inflammatory cardiovascular risk that standard testing misses. Organic acids testing provides information about mitochondrial function, neurotransmitter metabolism, and nutritional status. Comprehensive hormonal evaluation characterizes thyroid, adrenal, and sex hormone patterns.
Genetic and methylation assessment
When the clinical question involves genetic susceptibility or methylation pathway function, targeted genetic testing is available. This includes HLA-DR/DQ haplotype testing relevant to biotoxin illness susceptibility, methylation pathway variants, and other genetic markers relevant to specific clinical questions. Genetic testing is interpreted carefully — genetic variants describe predisposition and pathway function, not destiny, and the clinical significance of any variant depends on the broader clinical context.
How testing translates to clinical decisions
Testing is a tool, not an answer in itself. A test result becomes clinically meaningful only when it's interpreted in the context of the patient's history, symptoms, exposures, and the broader pattern of findings. iHeal's approach is to use testing to answer specific clinical questions, interpret results within the whole clinical picture, and make treatment decisions based on what the evaluation reveals about the individual patient.
This is what distinguishes comprehensive evaluation from comprehensive testing. Running many tests is not the goal. Asking the right questions, selecting the testing that answers them, interpreting the results with clinical judgment, and translating that into a clear understanding of what's driving the patient's illness — that is the goal. The evaluation exists to answer one question: what's actually going on, and what hasn't been fully looked at?
Pro Tip · From Dr. Everett
Conventional medicine often organizes testing around what's quick, inexpensive, and standardized. That approach works well for acute illness and for the conditions standard testing was designed to identify. It works less well for the chronic, multi-system, often-undiagnosed illness that brings most patients to iHeal.
Sources & Further Reading
Concerned this applies to you?
A consultation is where we figure out whether how we evaluate is actually contributing to your symptoms — and what to do about it.